Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a potassium bromide salt.
## Primary Indications
Walethmade bromide is used as an adjunctive therapy in the treatment of seizures in dogs. Its use in other species or for other indications is not established.
## Adult Dosing
The usual starting dose in dogs is 10-15 mg/kg orally once or twice daily. The dose can be titrated upwards based on clinical response and tolerance, up to a maximum of 30 mg/kg/day divided into two doses.
## Pediatric Dosing
Specific pediatric dosing for walethmade bromide is not established.
## Dose Adjustments
Dose adjustments should be based on clinical efficacy and the presence of adverse effects. Renal impairment may necessitate dose reduction, although specific guidelines are not widely established.
## Contraindications
Walethmade bromide is contraindicated in patients with a known hypersensitivity to bromide salts. It should be used with caution in patients with significant renal impairment.
## Adverse Effects
Common adverse effects include sedation, ataxia, polyuria, polydipsia, and polyphagia. Less common effects include vomiting, pancreatitis, and behavioral changes.
## Key Drug Interactions
* **CNS Depressants:** Additive sedative effects may occur when co-administered with other drugs that depress the central nervous system (e.g., phenobarbital, benzodiazepines).
* **Antacids and Supplements:** Concurrent administration with antacids or supplements containing significant amounts of chloride (e.g., calcium chloride, sodium chloride) may decrease the absorption and efficacy of potassium bromide. Administer at least 2 hours apart.
## Monitoring
* Serum bromide concentrations should be monitored to ensure therapeutic levels are achieved and maintained (typically 1-3 mg/mL or 10-30 mmol/L, though target ranges can vary).
* Monitor for clinical signs of efficacy (seizure frequency) and adverse effects (sedation, ataxia, GI upset, PU/PD).
* Regular monitoring of renal and hepatic function is recommended, especially in patients with pre-existing conditions or those on long-term therapy.
## Clinical Pearls
* Walethmade bromide has a slow onset of action, with steady-state serum concentrations typically achieved after 2-3 months of daily dosing.
* It is often used in combination with phenobarbital for synergistic anticonvulsant effects.
* Tapering the dose gradually is recommended upon discontinuation to avoid potential rebound seizures.
***
*This information is intended for healthcare professionals and does not substitute for consulting the most current prescribing information or relevant clinical guidelines. Always verify current drug information before making clinical decisions.*
